nach oben

04.05.2024 | Original Contribution

Coffee consumption might be associated with lower potential risk and severity of metabolic syndrome: national health and nutrition examination survey 2003–2018

verfasst von: He Zhao, Shuolin Wang, Yingdong Han, Menghui Yao, Yun Zhang, Xuejun Zeng

Erschienen in: European Journal of Nutrition

Einloggen, um Zugang zu erhalten

Abstract

Background

Metabolic syndrome (MetS) is a clinical syndrome characterized by multiple metabolic disorders and is a serious global health problem. The coffee effect, acting as one of the most prevalent beverages on metabolic syndrome, is debatable.

Methods

We included patients from the National Health and Nutrition Examination Survey 2003–2018 and used a comprehensive evaluation called the MetS z-score to assess the severity of metabolic syndrome. The relationship between coffee, decaffeinated coffee, tea, and MetS z-scores was explored using a weighted linear regression. We also divided the participants into metabolic and non-metabolic syndrome groups according to the NCEP/ATP III criteria for the subgroup analysis.

Results

A total of 14,504 participants were included in this study. The results demonstrated that drinking more than three cups of coffee daily was significantly linked to lower MetS z-scores (p < 0.001). Daily coffee consumption was also associated with lower BMI (p = 0.02), systolic blood pressure (p < 0.001), Homeostatic Model Assessment for Insulin Resistance (p < 0.001), and triglycerides (p < 0.001), while it was positively correlated with HDL-C (p = 0.001). Participants who consumed more than three cups of coffee daily had a lower MetS z-score in the MetS (p < 0.001) and non-MetS (p = 0.04) groups.

Conclusion

This research indicates that coffee consumption is linked to MetS severity. However, decaffeinated coffee and tea intake were unrelated to MetS severity.

Nur mit Berechtigung zugänglich

Ferraz-Amaro I, Gonzalez-Juanatey C, Lopez-Mejias R, Riancho-Zarrabeitia L, Gonzalez-Gay MA (2013) Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm 2013(710928). https://doi.org/10.1155/2013/710928

Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH (2008) The metabolic syndrome. Endocr Rev 29(7):777–822. https://doi.org/10.1210/er.2008-0024CrossRefPubMedPubMedCentral

Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365(9468):1415–1428. https://doi.org/10.1016/s0140-6736(05)66378-7CrossRefPubMed

Scholze J, Alegria E, Ferri C, Langham S, Stevens W, Jeffries D, Uhl-Hochgraeber K (2010) Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. BMC Public Health 10:529. https://doi.org/10.1186/1471-2458-10-529CrossRefPubMedPubMedCentral

Wu SH, Liu Z, Ho SC (2010) Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol 25(6):375–384. https://doi.org/10.1007/s10654-010-9459-zCrossRefPubMed

DeBoer MD, Filipp SL, Gurka MJ (2018) Use of a metabolic syndrome severity Z score to Track Risk during Treatment of prediabetes: an analysis of the Diabetes Prevention Program. Diabetes Care 41(11):2421–2430. https://doi.org/10.2337/dc18-1079CrossRefPubMedPubMedCentral

Shang F, Li X, Jiang X (2016) Coffee consumption and risk of the metabolic syndrome: a meta-analysis. Diabetes Metab 42(2):80–87. https://doi.org/10.1016/j.diabet.2015.09.001CrossRefPubMed

Lutsey PL, Steffen LM, Stevens J (2008) Dietary intake and the development of the metabolic syndrome: the atherosclerosis risk in communities study. Circulation 117(6):754–761. https://doi.org/10.1161/circulationaha.107.716159CrossRefPubMed

Chang CS, Chang YF, Liu PY, Chen CY, Tsai YS, Wu CH (2012) Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao old people (TOP) study 02. PLoS ONE 7(6):e38874. https://doi.org/10.1371/journal.pone.0038874CrossRefPubMedPubMedCentral

10.

Grosso G, Stepaniak U, Micek A, Topor-Mądry R, Pikhart H, Szafraniec K, Pająk A (2015) Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr 54(7):1129–1137. https://doi.org/10.1007/s00394-014-0789-6CrossRefPubMed

11.

Hino A, Adachi H, Enomoto M, Furuki K, Shigetoh Y, Ohtsuka M, Kumagae S, Hirai Y, Jalaldin A, Satoh A, Imaizumi T (2007) Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 76(3):383–389. https://doi.org/10.1016/j.diabres.2006.09.033CrossRefPubMed

12.

Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35(7):1605–1610. https://doi.org/10.2337/dc11-2339CrossRefPubMedPubMedCentral

13.

Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A (2015) Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metabol 19(1):160–164. https://doi.org/10.4103/2230-8210.146874CrossRef

14.

Sae-tan S, Grove KA, Lambert JD (2011) Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res 64(2):146–154. https://doi.org/10.1016/j.phrs.2010.12.013CrossRefPubMed

15.

Hino A, Adachi H, Enomoto M, Furuki K, Shigetoh Y, Ohtsuka M, Kumagae S-I, Hirai Y, Jalaldin A, Satoh A, Imaizumi T (2007) Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 76(3):383–389. https://doi.org/10.1016/j.diabres.2006.09.033CrossRefPubMed

16.

Chang C, Chang Y, Liu P, Chen C, Tsai Y, Wu C (2012) Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao old people (TOP) study 02. PLoS ONE 7(6):e38874. https://doi.org/10.1371/journal.pone.0038874CrossRefPubMedPubMedCentral

17.

Pham NM, Nanri A, Kochi T, Kuwahara K, Tsuruoka H, Kurotani K, Akter S, Kabe I, Sato M, Hayabuchi H, Mizoue T (2014) Coffee and green tea consumption is associated with insulin resistance in Japanese adults. Metabolism 63(3):400–408. https://doi.org/10.1016/j.metabol.2013.11.008CrossRefPubMed

18.

Moon SM, Joo MJ, Lee YS, Kim MG (2021) Effects of Coffee consumption on insulin resistance and sensitivity: a Meta-analysis. Nutrients 13(11). https://doi.org/10.3390/nu13113976

19.

van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 DiabetesA. Syst Rev JAMA 294(1):97–104. https://doi.org/10.1001/jama.294.1.97CrossRef

20.

Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132(6):2169–2180. https://doi.org/10.1053/j.gastro.2007.03.059CrossRefPubMed

21.

Henriksen EJ, Diamond-Stanic MK, Marchionne EM (2011) Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 51(5):993–999. https://doi.org/10.1016/j.freeradbiomed.2010.12.005CrossRefPubMed

22.

Yashin A, Yashin Y, Wang JY, Nemzer B (2013) Antioxidant and antiradical activity of coffee. Antioxid (Basel) 2(4):230–245. https://doi.org/10.3390/antiox2040230CrossRef

23.

Sharif K, Watad A, Bragazzi NL, Adawi M, Amital H, Shoenfeld Y (2017) Coffee and autoimmunity: more than a mere hot beverage! Autoimmun Rev 16(7):712–721. https://doi.org/10.1016/j.autrev.2017.05.007CrossRefPubMed

24.

Higdon JV, Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46(2):101–123. https://doi.org/10.1080/10408390500400009CrossRefPubMed

25.

Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR Jr., He K (2010) Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 33(12):2604–2610. https://doi.org/10.2337/dc10-0994CrossRefPubMedPubMedCentral

26.

Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Bes-Rastrollo M, Galvano F, Martinez-Gonzalez MA (2017) Long-term coffee consumption is Associated with decreased incidence of New-Onset Hypertension: a dose-response Meta-analysis. Nutrients 9(8). https://doi.org/10.3390/nu9080890

27.

Miranda AM, Goulart AC, Benseñor IM, Lotufo PA, Marchioni DM (2021) Coffee consumption and risk of hypertension: a prospective analysis in the cohort study. Clin Nutr 40(2):542–549. https://doi.org/10.1016/j.clnu.2020.05.052CrossRefPubMed

28.

Cicero AFG, Fogacci F, D’Addato S, Grandi E, Rizzoli E, Borghi C, Study obotBH (2023) Self-reported Coffee Consumption and Central and Peripheral Blood pressure in the cohort of the Brisighella Heart Study. Nutrients 15(2):312CrossRefPubMedPubMedCentral

29.

Jee SH, He J, Whelton PK, Suh I, Klag MJ (1999) The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 33(2):647–652. https://doi.org/10.1161/01.hyp.33.2.647CrossRefPubMed

30.

Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E (2011) The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 94(4):1113–1126. https://doi.org/10.3945/ajcn.111.016667CrossRefPubMed

31.

Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA (2002) Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105(16):1890–1896. https://doi.org/10.1161/01.cir.0000015126.83143.b4CrossRefPubMed

32.

Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, Li RK, Mickle DA, Verma S (2003) C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107(13):1783–1790. https://doi.org/10.1161/01.Cir.0000061916.95736.E5CrossRefPubMed

33.

Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, Hase T, Saito I (2007) Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens 20(5):508–513. https://doi.org/10.1016/j.amjhyper.2006.11.008CrossRefPubMed

34.

Godos J, Pluchinotta FR, Marventano S, Buscemi S, Li Volti G, Galvano F, Grosso G (2014) Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr 65(8):925–936. https://doi.org/10.3109/09637486.2014.940287CrossRefPubMed

35.

Wahrburg U, Martin H, Schulte H, Walek T, Assmann G (1994) Effects of two kinds of decaffeinated coffee on serum lipid profiles in healthy young adults. Eur J Clin Nutr 48(3):172–179PubMed

36.

Whayne TF Jr (2015) Coffee: a selected overview of Beneficial or Harmful effects on the Cardiovascular System? Curr Vasc Pharmacol 13(5):637–648CrossRefPubMed

37.

Du Y, Lv Y, Zha W, Hong X, Luo Q (2020) Effect of coffee consumption on dyslipidemia: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 30(12):2159–2170. https://doi.org/10.1016/j.numecd.2020.08.017CrossRefPubMed

38.

Zhou A, Hyppönen E (2021) Habitual coffee intake and plasma lipid profile: evidence from UK Biobank. Clin Nutr 40(6):4404–4413. https://doi.org/10.1016/j.clnu.2020.12.042CrossRefPubMed

39.

DeBoer MD, Filipp SL, Sims M, Musani SK, Gurka MJ (2020) Risk of ischemic stroke increases over the spectrum of metabolic syndrome severity. Stroke 51(8):2548–2552. https://doi.org/10.1161/strokeaha.120.028944CrossRefPubMedPubMedCentral

Titel: Coffee consumption might be associated with lower potential risk and severity of metabolic syndrome: national health and nutrition examination survey 2003–2018
verfasst von: He Zhao
Shuolin Wang
Yingdong Han
Menghui Yao
Yun Zhang
Xuejun Zeng
Publikationsdatum: 04.05.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-024-03367-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Coffee consumption might be associated with lower potential risk and severity of metabolic syndrome: national health and nutrition examination survey 2003–2018

Abstract

Background

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin